E28 Stock Analysis: FRENCKEN | SG

Scientific & Technical Instruments | SG, Singapore | Market Cap: 1.089m SGD | 12M Return: 63.6% | SG1R43925234 | Charts, Fundamentals & Technical Analysis

Mechatronic Systems, Electromechanical Assemblies, Plastic Mouldings, Filters
Total Rating 52
Safety 90
Buy Signal -0.02
Scientific & Technical Instruments
Industry Rotation: -2.1
Market Cap: 859M
Avg Turnover: 14.7M
Risk 3d forecast
Volatility46.1%
VaR 5th Pctl7.33%
VaR vs Median-3.53%
Reward TTM
Sharpe Ratio1.13
Rel. Str. IBD73.2
Rel. Str. Peer Group43.3
Character TTM
Beta1.396
Beta Downside1.089
Hurst Exponent0.391
Drawdowns 3y
Max DD50.35%
CAGR/Max DD0.60
CAGR/Mean DD1.83

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 11.6 years of data

Jan +1.9% 5
Feb -5.0% 23
Mar +3.0% 18
Apr -1.4% 10
May -2.1% 8
Jun +1.0% 8
Jul +2.9% 28
Aug -2.8% 11
Sep +0.0% 0
Oct -6.4% 35
Nov -0.6% 13
Dec -1.1% 17

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: E28 FRENCKEN

Frencken Group Limited is a Singapore-headquartered investment holding company founded in 1999 that operates across Singapore, the Netherlands, China, and Malaysia. It delivers original design, original equipment, and integrated manufacturing solutions through two core segments: Mechatronics, which serves OEM customers in the medical, semiconductor, analytical, pharmaceutical, industrial/factory automation, and aerospace end-markets with precision-engineered systems, parts, and value-added services; and Integrated Manufacturing Services (IMS), which provides contract design and manufacturing for the automotive and office automation industries, including plastic injection moulding, tooling, surface finishes, automated assembly, and component sub-assemblies. The group also holds property and offers ancillary services such as vacuum coating, thermal treatment, and adhesive/thermal management products.

The business model is that of a diversified contract manufacturer serving multiple end-markets, which typically helps smooth cyclicality across the semiconductor, automotive, and industrial automation cycles. As an SGX-listed small-cap in the Information Technology sector (Electronic Components sub-industry), Frencken operates in a highly competitive global EMS/ODM landscape where peers range from large multinational manufacturers to specialised regional precision-engineering firms, with margin profiles often shaped by design value-add versus volume assembly work.

Headlines to Watch Out For
  • Semiconductor equipment cycle lifts mechatronics precision engineering orders
  • Automotive and office automation softness weighs on IMS segment margins
  • US-China trade tensions expose manufacturing footprint to tariff risks
Piotroski VR-10 (Strict) 6.0
Net Income: 39.1m TTM > 0 and > 6% of Revenue
FCF/TA: 0.20 > 0.02 and ΔFCF/TA 7.96 > 1.0
NWC/Revenue: 38.03% < 20% (prev 36.37%; Δ 1.67% < -1%)
CFO/TA 0.23 > 3% & CFO 166.7m > Net Income 39.1m
Net Debt (-94.1m) to EBITDA (79.5m): -1.18 < 3
Current Ratio: 2.68 > 1.5 & < 3
Outstanding Shares: last quarter (427.1m) vs 12m ago 0.02% < -2%
Gross Margin: 14.26% > 18% (prev 14.52%; Δ -0.26% > 0.5%)
Asset Turnover: 117.3% > 50% (prev 108.1%; Δ 9.22% > 0%)
Interest Coverage Ratio: 8.97 > 6 (EBIT TTM 48.0m / Interest Expense TTM 5.35m)
Altman Z'' 6.88
A: 0.44 (Total Current Assets 524.3m - Total Current Liabilities 195.3m) / Total Assets 740.2m
B: 0.50 (Retained Earnings 367.1m / Total Assets 740.2m)
C: 0.07 (EBIT TTM 48.0m / Avg Total Assets 737.7m)
D: 1.82 (Book Value of Equity 475.3m / Total Liabilities 261.4m)
Altman-Z'' = 6.88 = AAA
Beneish M -2.99
DSRI: 0.93 (Receivables 138.9m/137.8m, Revenue 865.1m/794.3m)
GMI: 1.02 (GM 14.52% / 14.26%)
AQI: 1.06 (AQ_t 0.04 / AQ_t-1 0.04)
SGI: 1.09 (Revenue 865.1m / 794.3m)
TATA: -0.17 (NI 39.1m - CFO 166.7m) / TA 740.2m)
Beneish M = -2.99 (Cap -4..+1) = A
What is the price of E28 shares?

As of September 07, 2026, the stock is trading at SGD 2.30 with a total of 11,168,100 shares traded. Over the past week, the price has changed by -2.13%, over one month by -11.54%, over three months by -23.33% and over the past year by +63.62%.

Current recommended Stop Loss: 2.00 (which is 13% or 2.7 ATR below the current price).

Is E28 a buy, sell or hold?

FRENCKEN has no consensus analysts rating.

FRENCKEN (E28) - Fundamental Data Overview as of 05 September 2026
Market Cap USD = 859.5m (1.09b SGD * 0.7891 SGD.USD)
P/E Trailing = 25.5556
P/E Forward = 18.3824
P/S = 1.2642
P/B = 2.0034
P/EG = 1.4704
Revenue TTM = 865.1m SGD
EBIT TTM = 48.0m SGD
EBITDA TTM = 79.5m SGD
Long Term Debt = 585k SGD (from longTermDebt, last quarter)
Short Term Debt = 21.7m SGD (from shortLongTermDebt, last quarter)
Debt = 67.8m SGD (Leases only: 67.8m)
Net Debt = -94.1m SGD (calculated: Debt 67.8m - CCE 161.9m)
Enterprise Value = 995.1m SGD (1.09b + Debt 67.8m - CCE 161.9m)
Interest Coverage Ratio = 8.97 (Ebit TTM 48.0m / Interest Expense TTM 5.35m)
EV/FCF = 6.77x (Enterprise Value 995.1m / FCF TTM 147.0m)
FCF Yield = 14.78% (FCF TTM 147.0m / Enterprise Value 995.1m)
FCF Margin = 17.00% (FCF TTM 147.0m / Revenue TTM 865.1m)
Net Margin = 4.52% (Net Income TTM 39.1m / Revenue TTM 865.1m)
Gross Margin = 14.26% ((Revenue TTM 865.1m - Cost of Revenue TTM 741.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 1.34 (Enterprise Value 995.1m / Total Assets 740.2m)
Interest Expense / Debt = 7.90% (Interest Expense 5.35m / Debt 67.8m)
Taxrate = 20.41% (10.1m / 49.4m)
NOPAT = 38.2m (EBIT 48.0m * (1 - 20.41%))
Current Ratio = 2.68 (Total Current Assets 524.3m / Total Current Liabilities 195.3m)
Debt / Equity = 0.14 (Debt 67.8m / totalStockholderEquity, last quarter 475.3m)
Debt / EBITDA = -1.18 (Net Debt -94.1m / EBITDA 79.5m)
Debt / FCF = -0.64 (Net Debt -94.1m / FCF TTM 147.0m)
Total Stockholder Equity = 440.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.30% (Net Income 39.1m / Total Assets 740.2m)
RoE = 8.87% (Net Income TTM 39.1m / Total Stockholder Equity 440.9m)
RoCE = 10.87% (EBIT 48.0m / Capital Employed (Equity 440.9m + L.T.Debt 585k))
RoIC = 7.61% (NOPAT 38.2m / Invested Capital 501.7m)
WACC = 10.62% (E(1.09b)/V(1.16b) * Re(10.89%) + D(67.8m)/V(1.16b) * Rd(7.90%) * (1-Tc(0.20)))
Discount Rate = 10.89% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 67.05 | Cagr: 0.06%
[DCF] Terminal Value 70.99% ; FCFF base≈123.2m ; Y1≈141.3m ; Y5≈207.9m
[DCF] Fair Price = 4.91 (EV 2.23b - Net Debt -94.1m = Equity 2.33b / Shares 473.6m; r=10.62% [WACC]; 5y FCF grow 15.0% → 2.50% )
Revenue Correlation: 99.76 | Revenue CAGR: 7.92% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=0.10 | Chg30d=-0.98% | Revisions=-50% | GrowthEPS=+10.8% | GrowthRev=+4.9%
EPS next Year (2027-12-31): EPS=0.12 | Chg30d=-0.42% | Revisions=+17% | GrowthEPS=+16.2% | GrowthRev=+9.2%
[Analyst] Revisions Ratio: -22% (up=2, down=4)